Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Haemonetics Corp.
Swot
Haemonetics Corp. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Haemonetics Corp. has 7 Strengths, 12 Weaknesses, 3 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(7)
Weakness
(12)
Opportunity
(3)
Threats
(2)
Others
(1)
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Significant (over 30%) distance from 52 week high
PE less than Industry PE
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Annual Net Profits improving for last 2 years
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Top Losers
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Declining Revenue every quarter for the past 2 quarters
RSI indicating price weakness
Near 52 Week Low
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter
Promoters increasing shareholding QoQ
